CN105851825A - 一种适合冠心病患者食用的养生粥及其制备方法 - Google Patents
一种适合冠心病患者食用的养生粥及其制备方法 Download PDFInfo
- Publication number
- CN105851825A CN105851825A CN201610357050.4A CN201610357050A CN105851825A CN 105851825 A CN105851825 A CN 105851825A CN 201610357050 A CN201610357050 A CN 201610357050A CN 105851825 A CN105851825 A CN 105851825A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- heart disease
- coronary heart
- edible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 51
- 235000021395 porridge Nutrition 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 30
- 235000001715 Lentinula edodes Nutrition 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims description 70
- 238000009835 boiling Methods 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 241000221377 Auricularia Species 0.000 claims description 29
- 239000002994 raw material Substances 0.000 claims description 23
- 235000013312 flour Nutrition 0.000 claims description 22
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 241000411851 herbal medicine Species 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 238000002791 soaking Methods 0.000 claims description 11
- 230000007159 enucleation Effects 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 35
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 8
- 208000026435 phlegm Diseases 0.000 abstract description 8
- 208000002193 Pain Diseases 0.000 abstract description 7
- 230000036407 pain Effects 0.000 abstract description 7
- 235000008935 nutritious Nutrition 0.000 abstract description 4
- 230000001914 calming effect Effects 0.000 abstract description 3
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 235000012054 meals Nutrition 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 240000008467 Oryza sativa Japonica Group Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000003143 atherosclerotic effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- -1 flavone compound Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010042434 Sudden death Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- IOYNGCZNYGEZRO-UHFFFAOYSA-N 3-ethyl-n,n,2-trimethyl-1h-indol-5-amine Chemical compound C1=C(N(C)C)C=C2C(CC)=C(C)NC2=C1 IOYNGCZNYGEZRO-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000514745 Mactra Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 240000005166 Polygonatum biflorum Species 0.000 description 1
- 235000004506 Polygonatum multiflorum Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 244000181066 Rosa eglanteria Species 0.000 description 1
- 235000000542 Rosa eglanteria Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000001518 anti-nephritic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 206010046885 vaginal cancer Diseases 0.000 description 1
- 208000013139 vaginal neoplasm Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种适合冠心病患者食用的养生粥及其制备方法,该养生粥取下述重量配比的主要原料制备而成:粳米20‑40份、玉米面10‑20份、茯苓10‑20份、黄精10‑20份、山楂8‑16份、香菇5‑15份、木耳5‑15份、百合5‑15份、桃仁4‑12份、郁金2‑8份、西红花2‑8份、陈皮2‑8份、生姜1‑5份、广枣1‑3份。本发明提供的养生粥采用药食两用的中药材,配方科学,制备简单、营养美味、无毒副作用、成本低廉,具有活血化瘀、益气养阴、化痰止痛、宁心安神的功效,特别适合冠心病患者食用。
Description
技术领域
本发明涉及养生粥领域,特别是涉及一种适合冠心病患者食用的养生粥及其制备方法。
背景技术
“冠心病”是冠状动脉粥样硬化性心脏病的简称,是冠状动脉血管发生动脉粥样硬化病变而引起血管腔狭窄或阻塞,造成心肌缺血、缺氧或坏死而导致的心脏病。世界卫生组织将冠心病分为5大类:无症状心肌缺血、心绞痛、心肌梗死、缺血性心力衰竭和猝死5种临床类型。常见症状为: 典型胸痛,心前区不适,心悸,乏力,猝死,发热,出汗,惊恐,恶心,呕吐,心力衰竭等。
冠心病的主要病因是冠状动脉粥样硬化,但动脉粥样硬化的原因尚不完全清楚,可能是与高血压、高脂血症、高粘血症、糖尿病、内分泌功能低下及年龄、家族史等因素有关。此外,冠心病的发作常常与季节变化、情绪激动、体力活动增加、饱食、大量吸烟和饮酒等有关。因此,冠心病患者平时要注意饮食:控制膳食总热量,低脂,低胆固醇膳食,并限制蔗糖及含糖食物的摄入。注意饮食清淡,多食富含维生素C和植物蛋白的食物。
然而目前特意为冠心病患者准备的饮食还很少,粥类作为一种营养丰富、保健养生的食物愈加成为人们必不可少的饮食,因此,有必要开发一种适合冠心病患者食用的养生粥。
发明内容
本发明的目的之一是提供一种制备简单、成本低廉、营养丰富,并适合冠心病患者食用的养生粥。
为了解决上述技术问题,本发明所采用的技术方案是:
一种适合冠心病患者食用的养生粥,取下述重量配比的主要原料制备而成:粳米20-40份、玉米面10-20份、茯苓10-20份、黄精10-20份、山楂8-16份、香菇5-15份、木耳5-15份、百合5-15份、桃仁4-12份、郁金2-8份、西红花2-8份、陈皮2-8份、生姜1-5份、广枣1-3份。
一种适合冠心病患者食用的养生粥,优选的方案,取下述重量配比的主要原料制备而成:粳米25-35份、玉米面13-17份、茯苓13-17份、黄精13-17份、山楂10-14份、香菇8-12份、木耳8-12份、百合8-12份、桃仁6-10份、郁金4-6份、西红花4-6份、陈皮4-6份、生姜2-4份、广枣1.5-2.5份。
一种适合冠心病患者食用的养生粥,更加优选的方案,取下述重量配比的主要原料制备而成:粳米30份、玉米面15份、茯苓15份、黄精15份、山楂12份、香菇10份、木耳10份、百合10份、桃仁8份、郁金5份、西红花5份、陈皮5份、生姜3份、广枣2份。
本发明的另一目的是提供上述适合冠心病患者食用的养生粥的制备方法。
一种适合冠心病患者食用的养生粥的制备方法,步骤如下:
步骤一:将粳米洗净,用水浸泡2-4小时,将玉米面加入其重量2-4倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量8-12倍的水,浸泡10-20分钟后,武火煎煮至沸腾,转文火煎煮20-40分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮15-25分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮5-15分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
上述适合冠心病患者食用的养生粥的制备方法,步骤一中将粳米洗净,用水浸泡2.5-3.5小时,将玉米面加入其重量2.5-3.5倍的水;优选的,将粳米洗净,用水浸泡3小时,将玉米面加入其重量3倍的水。
上述适合冠心病患者食用的养生粥的制备方法,步骤三中加原料重量9-11倍的水,浸泡13-17分钟后,武火煎煮至沸腾,转文火煎煮25-35分钟后,将包煎袋取出,得到中药煎煮液;优选的,加原料重量10倍的水,浸泡15分钟后,武火煎煮至沸腾,转文火煎煮30分钟后,将包煎袋取出,得到中药煎煮液。
上述适合冠心病患者食用的养生粥的制备方法,步骤四中文火煎煮18-22分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮8-12分钟后,停火;优选的,文火煎煮20分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮10分钟后,停火。
本发明所用主要原料的药理功效如下:
粳米:性平、味甘,归脾、胃经;具有补中益气,平和五脏,止烦渴,止泄,壮筋骨,通血脉,益精强志,好颜色之功;主治泻痢、胃气不足、口干渴、呕吐、诸虚百损等。
玉米面:其中含有大量的卵磷脂、亚油酸、谷物醇、维生素E、纤维素等,具有降血压、降血脂、抗动脉硬化、预防肠癌、美容养颜、延缓衰老等多种保健功效,也是糖尿病人的适宜佳品。
茯苓:性平,味甘、淡。归心经、肺经、脾经、肾经。功效与作用:利水渗湿、健脾宁心。用治水肿尿少、痰饮眩悸、脾虚食少、便溏泄泻、心神不安、惊悸失眠。具有利尿、抗菌作用,能提高机体的免疫能力。此外,还有降低血糖、降低胃酸、增强离体心脏心缩等作用。
黄精:性平,味甘。归肺经、脾经、肾经。功效与作用:补气养阴、健脾、润肺、益肾。黄精能增加冠脉流量、调血脂、降血糖、抗衰老和增强免疫。黄精粗多糖具免疫调节作用,对化学性肝损伤具保护作用,另具抗炎和抗病毒作用。此外,还具抑菌作用。用治脾胃虚弱、体倦乏力、口干食少、肺虚燥咳、精血不足、内热消渴。现代临床用治冠心病、高脂血症、糖尿病、白细胞减少症、肺结核、慢性肝炎、脑力及睡眠不足、头痛、阳痿及癣菌病等。
山楂:性微温,味酸、甘。归脾经、胃经、肝经。主要含有机酸及黄酮类化合物。山楂中有机酸是消食导滞的有效成分,黄酮类化合物是防治心血管病及降血脂的活性成分。功效与作用:消食健脾、行气消瘀。内服治疗肉食积滞、小儿乳积、脘腹胀痛、痢疾、泄泻、痛经、产后瘀血腹痛、高血脂症等。
香菇:性寒、味微苦,有利肝益胃、 降血压、降血脂、降胆固醇的功效。可防止动脉粥样硬化,对防治脑溢血、心脏病、肥胖症和糖尿病都有效。
木耳:性平,味甘。归肺经、脾经、大肠经、肝经。功效与作用:补气养血,润肺止咳,止血,降压,抗癌。主治气虚血亏,肺虚久咳,咯血,衄血,血痢,痔疮出血,妇女崩漏,高血压,眼底出血,子宫颈癌,阴道癌,跌打伤痛。
百合:性寒,味甘。归心经、肺经。功效与作用:养阴润肺、清心安神。属补虚药下分类的补阴药。用治阴虚久咳、痰中带血、虚烦惊悸、失眠多梦、精神恍惚。
桃仁 :性平,味苦、甘。归心经、肝经、大肠经。含苦杏仁苷、野樱桃苷、2,4-次甲基珂阿尔廷醇、多花蔷薇苷、尿囊素、维生素B1、苦杏仁酶、脂肪油、脂肪酸、蛋白质等。具有抗凝血、改善血流、抗炎和抗过敏等作用。并能止咳、平喘,对肺结核有一定疗效。功效与作用:活血祛痰、润肠通便。用治经闭、痛经、痞块、跌扑损伤、肠燥便秘。
郁金:性寒,味辛、苦。归肝、心、肺经。功效与作用:活血止痛、行气化疥、清心解郁、利胆退黄。用治经闭痛经、热病神昏、癫痫发狂、黄疸尿赤、胸腹胀痛、刺痛。
西红花:性平,味甘。归心经、肝经。功效与作用:活血化瘀、凉血解毒、解郁安神。有兴奋子宫、活血与止血、抗肾炎、抗动脉粥样硬化、抗癌、抗自由基氧化、促进视网膜动脉血流量等作用。用治经闭、产后瘀阻、温毒发斑、忧郁痞闷、惊悸发狂等。
陈皮:味辛、味苦,性温。归胃经、肺经。功效与作用:理气开胃,燥湿化痰,治脾胃病。还具有抗胃溃疡、保肝利胆、升压、强心、扩张冠脉及抗肿瘤作用。用治胸脘胀满、食少呕吐、咳嗽痰多。
生姜 :性微温,味辛。归肺经、脾经、胃经。药理:有镇静及抗惊厥作用;有解热、镇痛和抗炎作用;松弛胃肠道平滑肌;止吐和抗运动病;兴奋心脏,增强心房收缩力,保护胃黏膜;保肝利胆;抗血小板聚集;抗5-羟色胺,抗氧化,抗微生物,中枢兴奋,促进体内活性物质释放,促进吸收,止咳,降血脂,抗过敏,诱变和抗诱变,抑制亚硝胺合成。功效与作用:散寒解表,降逆止呕,化痰止咳,解鱼蟹毒。用于风寒感冒,胃寒呕吐,寒痰咳嗽,鱼蟹中毒。
广枣:性平,味甘、酸。归经暂无。主要成分:含黄酮、酚酸类化合物、氨基酸等成分。有效成分总黄酮有抗缺氧和对急性心肌缺血有保护作用,且在多种动物模型上均有显著抗心率失常、抗血小板凝集和增强免疫等作用。功效与作用:行气活血、养心、安神。用治气滞血瘀、胸痹作痛、心悸气短、心神不安。
本发明提供的养生粥配方科学,制备方法简单,除此之外,本发明的优良效果还表现在:
1、所选原料皆为常见的药食两用的中药材,营养丰富,无任何毒副作用;
2、药源易得,药材成本低廉,能够减轻患者负担。
3、本组方完全符合中医药“整体调理、辨证施治”原则,具有活血化瘀、益气养阴、化痰止痛、宁心安神的功效,特别适于冠心病患者食用。
具体实施方式
下面结合实施例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1一种适合冠心病患者食用的养生粥,取下述重量配比的主要原料制备而成(每份取1g):粳米20份、玉米面10份、茯苓10份、黄精10份、山楂8份、香菇5份、木耳5份、百合5份、桃仁4份、郁金2份、西红花2份、陈皮2份、生姜1份、广枣1份。
上述适合冠心病患者食用的养生粥的制备方法,步骤如下:
步骤一:将粳米洗净,用水浸泡2小时,将玉米面加入其重量2倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量8倍的水,浸泡10分钟后,武火煎煮至沸腾,转文火煎煮20分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮15分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮5分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
典型案例一:吴XX,女,65岁,山东济阳人,患者有5年的冠心病病史,长期反复出现前胸部剧烈疼痛,伴胸部紧迫感,发作时伴出汗、心跳,每次发作持续2-3分钟,舌下含服酸甘油后缓解,后经人建议食用本发明实施例1中的养生粥,坚持食用半月后,胸部疼痛减轻,发作频率减少,继续食用1个月后,症状好转,病情稳定。
实施例2一种适合冠心病患者食用的养生粥,取下述重量配比的主要原料制备而成(每份取1g):粳米40份、玉米面20份、茯苓20份、黄精20份、山楂16份、香菇15份、木耳15份、百合15份、桃仁12份、郁金8份、西红花8份、陈皮8份、生姜5份、广枣3份。
上述适合冠心病患者食用的养生粥的制备方法,步骤如下:
步骤一:将粳米洗净,用水浸泡4小时,将玉米面加入其重量4倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量12倍的水,浸泡20分钟后,武火煎煮至沸腾,转文火煎煮40分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮25分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮15分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
实施例3一种适合冠心病患者食用的养生粥,取下述重量配比的主要原料制备而成(每份取1g):粳米25份、玉米面13份、茯苓13份、黄精13份、山楂10份、香菇8份、木耳8份、百合8份、桃仁6份、郁金4份、西红花4份、陈皮4份、生姜2份、广枣1.5份。
上述适合冠心病患者食用的养生粥的制备方法,步骤如下:
步骤一:将粳米洗净,用水浸泡2.5小时,将玉米面加入其重量2.5倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量9倍的水,浸泡13分钟后,武火煎煮至沸腾,转文火煎煮25分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮18分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮8分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
典型案例二:牛XX,男,50岁,山东济南人,患者之前有高血压病史,1年前出现胸闷、憋气、咳嗽的症状,去医院检查Bp120/93mmHg,口唇轻度紫绀,颈静脉无怒张,双肺呼吸音粗,双肺底可闻及湿啰音。心浊音界向左下扩大,心率108次/分,律绝对不规整,第一心音强弱不等,各瓣膜听诊区未闻及病理性杂音。被诊断为冠状动脉粥样硬化性心脏病,医生建议其服用本发明实施例3中的养生粥,服用1周后,胸闷、憋气、咳嗽的症状减轻,血压降低,继续服用2个月后,血压稳定,不适症状完全消失,至今无复发。
实施例4一种适合冠心病患者食用的养生粥,取下述重量配比的主要原料制备而成(每份取1g):粳米35份、玉米面17份、茯苓17份、黄精17份、山楂14份、香菇12份、木耳12份、百合12份、桃仁10份、郁金6份、西红花6份、陈皮6份、生姜4份、广枣2.5份。
上述适合冠心病患者食用的养生粥的制备方法,步骤如下:
步骤一:将粳米洗净,用水浸泡3.5小时,将玉米面加入其重量3.5倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量11倍的水,浸泡17分钟后,武火煎煮至沸腾,转文火煎煮35分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮22分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮12分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
实施例5一种适合冠心病患者食用的养生粥,取下述重量配比的主要原料制备而成(每份取1g):粳米30份、玉米面15份、茯苓15份、黄精15份、山楂12份、香菇10份、木耳10份、百合10份、桃仁8份、郁金5份、西红花5份、陈皮5份、生姜3份、广枣2份。
上述适合冠心病患者食用的养生粥的制备方法,步骤如下:
步骤一:将粳米洗净,用水浸泡3小时,将玉米面加入其重量3倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量10倍的水,浸泡15分钟后,武火煎煮至沸腾,转文火煎煮30分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮20分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮10分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
Claims (9)
1.一种适合冠心病患者食用的养生粥,其特征在于:取下述重量配比的主要原料制备而成:粳米20-40份、玉米面10-20份、茯苓10-20份、黄精10-20份、山楂8-16份、香菇5-15份、木耳5-15份、百合5-15份、桃仁4-12份、郁金2-8份、西红花2-8份、陈皮2-8份、生姜1-5份、广枣1-3份。
2.根据权利要求1所述的一种适合冠心病患者食用的养生粥,其特征在于:取下述重量配比的主要原料制备而成:粳米30份、玉米面15份、茯苓15份、黄精15份、山楂12份、香菇10份、木耳10份、百合10份、桃仁8份、郁金5份、西红花5份、陈皮5份、生姜3份、广枣2份。
3.一种根据权利要求1-2任一项所述的适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤如下:
步骤一:将粳米洗净,用水浸泡2-4小时,将玉米面加入其重量2-4倍的水,边加水边搅拌,调成玉米糊,备用;
步骤二:将香菇、木耳洗净泡开,山楂去核洗净,然后均切成细丁备用;
步骤三:将茯苓、黄精、百合、桃仁、郁金、西红花、陈皮、生姜、广枣洗净,切成细丁,装入包煎袋,把口扎好,置于砂锅内,加原料重量8-12倍的水,浸泡10-20分钟后,武火煎煮至沸腾,转文火煎煮20-40分钟后,将包煎袋取出,得到中药煎煮液;
步骤四:向中药煎煮液中加入步骤一洗净的粳米和玉米糊,文火煎煮15-25分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮5-15分钟后,停火,密封静置到室温即得适合冠心病患者食用的养生粥。
4.根据权利要求3所述的一种适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤一中将粳米洗净,用水浸泡2.5-3.5小时,将玉米面加入其重量2.5-3.5倍的水。
5.根据权利要求4所述的一种适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤一中将粳米洗净,用水浸泡3小时,将玉米面加入其重量3倍的水。
6.根据权利要求3所述的一种适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤三中加原料重量9-11倍的水,浸泡13-17分钟后,武火煎煮至沸腾,转文火煎煮25-35分钟后,将包煎袋取出,得到中药煎煮液。
7.根据权利要求6所述的一种适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤三中加原料重量10倍的水,浸泡15分钟后,武火煎煮至沸腾,转文火煎煮30分钟后,将包煎袋取出,得到中药煎煮液。
8.根据权利要求3所述的一种适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤四中文火煎煮18-22分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮8-12分钟后,停火。
9.根据权利要求8所述的一种适合冠心病患者食用的养生粥的制备方法,其特征在于:步骤四中文火煎煮20分钟后,加入步骤二得到的香菇、木耳、山楂细丁,继续煮10分钟后,停火。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610357050.4A CN105851825A (zh) | 2016-05-26 | 2016-05-26 | 一种适合冠心病患者食用的养生粥及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610357050.4A CN105851825A (zh) | 2016-05-26 | 2016-05-26 | 一种适合冠心病患者食用的养生粥及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105851825A true CN105851825A (zh) | 2016-08-17 |
Family
ID=56642140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610357050.4A Withdrawn CN105851825A (zh) | 2016-05-26 | 2016-05-26 | 一种适合冠心病患者食用的养生粥及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105851825A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018201575A1 (zh) * | 2017-04-30 | 2018-11-08 | 朱秀青 | 一种药膳粥 |
-
2016
- 2016-05-26 CN CN201610357050.4A patent/CN105851825A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018201575A1 (zh) * | 2017-04-30 | 2018-11-08 | 朱秀青 | 一种药膳粥 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102068707B (zh) | 一种b超使用的中药助影剂及其制备方法 | |
CN103301436B (zh) | 一种减肥降脂的药物 | |
CN110447902B (zh) | 一种具有减肥功效的组合物 | |
KR20170062755A (ko) | 한약재를 이용한 장어탕의 제조방법 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN104273439A (zh) | 一种健脾开胃的面条及其制作方法 | |
CN105661299A (zh) | 一种绣球菌保健粥 | |
CN104474487A (zh) | 补脾和胃酒 | |
CN105851825A (zh) | 一种适合冠心病患者食用的养生粥及其制备方法 | |
CN103734609B (zh) | 增强心脑供血,供氧,健脾补气,养血补肾药食同膳面 | |
KR20180056199A (ko) | 모링가추출물을 함유한 다이어트용 껌의 제조방법 | |
CN105995279A (zh) | 一种调节女性月经不调的保健饮品及其制备方法 | |
CN104383222A (zh) | 治疗冠心病的中药酒 | |
CN104605268A (zh) | 具有治疗糖尿病患功效的猪肚粥及制备方法 | |
CN105105127A (zh) | 一种红果舒心粉多功能保健食品 | |
CN104922504A (zh) | 治疗动脉粥样硬化的醋饮及制备方法 | |
CN103892006A (zh) | 健脑益寿茶 | |
CN108967757A (zh) | 一种红枣生姜浓浆生产工艺 | |
CN106387881A (zh) | 一种祛湿膳食粉及其制备方法 | |
CN106359737A (zh) | 一种蜂蜜红茶及其制备方法 | |
CN106387884A (zh) | 一种清润膳食粉及其制备方法 | |
CN106509609A (zh) | 一种食用菌保健粥 | |
CN105687530A (zh) | 一种抗癌药及其制备方法、用途 | |
CN105943941A (zh) | 一种祛湿减肥中药组合物 | |
CN105079613A (zh) | 有助于促进消化的营养鲜奶及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160817 |
|
WW01 | Invention patent application withdrawn after publication |